Skip to main content

Peer Review reports

From: A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol

Original Submission
31 May 2021 Submitted Original manuscript
8 Aug 2021 Reviewed Reviewer Report - Riaz Qureshi
8 Sep 2021 Author responded Author comments - I García-García
Resubmission - Version 2
8 Sep 2021 Submitted Manuscript version 2
14 Sep 2021 Editorially accepted
2 Oct 2021 Article published 10.1186/s13063-021-05625-7

You can find further information about peer review here.

Back to article page